Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...

Learn more about why a stressful job can lead to poor sleep and what can be done about it.

Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

As Zepbound causes thyroid C-cell tumors in ... over time to continue experiencing a benefit for sleep apnea.” At least 25 million adults in the U.S. have sleep apnea, according to the National ...

As Zepbound causes thyroid C-cell tumors in rats ... weight loss from Zepbound must be maintained over time to continue experiencing a benefit for sleep apnea.” At least 25 million adults in the U.S.

Statistics show that obstructive sleep apnea (OSA) is a common disorder affecting around 30 million adults in the US. In a recent press release, the American Food and Drug Administration has ...

On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound (tirzepatide) to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The drug is to be ...